Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on RBS's remaining State Aid obligation

26 Jul 2017 16:31

RNS Number : 1995M
Royal Bank of Scotland Group PLC
26 July 2017
 

 

The Royal Bank of Scotland Group plc

 

Update on RBS's remaining State Aid obligation regarding the business previously described as Williams & Glyn

 

26 July 2017

 

 

Following the consultation process carried out by the European Commission ("EC") and a market testing exercise carried out by HM Treasury ("HMT"), RBS has been informed by HMT that an alternative remedies package has now been agreed in principle between HMT and the EC Commissioner responsible for competition.

 

 

This revised package is focused on the following two remedies to promote competition in the market for banking services to small and medium enterprises ("SMEs") in the UK.

 

· A £425m Capability and Innovation Fund, to be administered by an independent body, that will grant funding to a range of competitors in the UK banking and financial technology sectors; and

· An Incentivised Switching Scheme which will provide £275m of funding for eligible challenger banks to help them incentivise SME customers of the business previously described as Williams & Glyn to switch their accounts and loans from RBS paid in the form of "dowries" to the receiving bank. An additional £75m will be made available by RBS to cover customers' costs of switching.

 

This revised package will be submitted to the EC's College of Commissioners for approval and if agreed will form the basis of a new term sheet in relation to RBS's remaining State Aid commitments. It is expected to come into effect during H2 2017, upon which RBS will no longer be obliged to achieve separation and divestment of the business previously described as Williams & Glyn by 31 December 2017.

 

A £750m provision was recognised in RBS's 2016 Annual Results in relation to the previously proposed package of measures. An incremental charge of £50m in relation to the revised package and its implementation costs will be recorded in the RBS H1 2017 results which will be announced 4th August 2017, taking the total provision to £800m.

 

RBS will incur running costs for the duration of the scheme, which are estimated at around £35m and will be substantially incurred before the end of 2019. Furthermore, under the terms of the revised package, should the uptake within the Incentivised Switching Scheme not be sufficient, RBS could be required to make a further contribution, capped at £50m.

 

Ross McEwan, RBS CEO, said "We welcome the progress that HMT and the EC Commissioner responsible for competition have made on agreeing an alternative package of remedies to increase competition in the SME marketplace. We await a formal decision on this proposal which would allow us to resolve our final State Aid divestment obligation."

 

 

Investor Relations

+44 (0) 20 7672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

MAR

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEDIIRFID
Date   Source Headline
28th Apr 201510:58 amRNSRBS Announces Management Change at Williams & Glyn
27th Apr 20157:00 amRNSFurther Sale of North American Loan Portfolio
23rd Apr 20155:22 pmRNSDividend Declaration
22nd Apr 201512:21 pmRNSCitizens 1Q 2015 Results
15th Apr 20155:56 pmRNSAllotment and Issue of New Ordinary Shares
13th Apr 201511:30 amRNSBlock Listing Return
2nd Apr 20155:59 pmRNSPublication of Registration Document
2nd Apr 20155:57 pmRNSPublication of Prospectus
2nd Apr 20154:56 pmRNSForm TR-1
1st Apr 20159:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F
31st Mar 20156:27 pmRNSAnnual Report and Accounts 2014
31st Mar 20155:18 pmRNSTotal Voting Rights
30th Mar 20151:07 pmRNSManagement Changes
27th Mar 20157:30 amRNSDisposal of Private Banking and Wealth Businesses
26th Mar 20157:03 amRNSDirector Declaration
26th Mar 20157:01 amRNSPartial Sale of Citizens Financial Group, Inc.
24th Mar 20159:45 amRNSMorgan Stanley European Financials Conference
23rd Mar 201511:03 amRNSIntention to Sell Part of Citizens Financial Group
18th Mar 20157:30 amRNSDe-listing of Ordinary Shares from Euronext
9th Mar 20154:13 pmRNSDirector/PDMR Shareholding
6th Mar 20151:02 pmRNSDirector/PDMR Shareholding
6th Mar 20151:00 pmRNSRemuneration Disclosures
27th Feb 20154:56 pmRNSTotal Voting Rights
26th Feb 20154:27 pmRNSTR1A
26th Feb 20157:05 amRNSSale of North American loan portfolio
26th Feb 20157:02 amRNSDirectorate Change
26th Feb 20157:02 amRNSFinal Results - Part 2
26th Feb 20157:01 amRNSFinal Results - Part 1
19th Feb 20155:45 pmRNSDividend Declaration
19th Feb 20153:00 pmRNSAdditional Listing
3rd Feb 20155:56 pmRNSRBS notes credit ratings downgrade by S&P
30th Jan 20154:05 pmRNSTotal Voting Rights
29th Jan 201510:29 amRNSForm 8.3 - [WYG plc]
26th Jan 201512:12 pmRNSCitizens Full Year 2014 Results
21st Jan 20153:41 pmRNSNotices of Redemption
15th Jan 201512:28 pmRNSHolding(s) in Company
8th Jan 201512:20 pmRNSNotice of Redemption
8th Jan 201512:13 pmRNSNotice of Redemption
31st Dec 201412:07 pmRNSTotal Voting Rights
23rd Dec 20141:20 pmRNSNotices of Redemption
23rd Dec 201411:40 amRNSPublication of Prospectus
18th Dec 20143:00 pmRNSNotice of Redemption
16th Dec 20147:30 amRNSSale of a Portfolio of Irish Real Estate Loans
16th Dec 20147:05 amRNS2014 Bank of England Stress Test Results
15th Dec 20144:45 pmRNSHolding(s) in Company
9th Dec 20145:00 pmRNSDirector/PDMR Shareholding
5th Dec 20142:00 pmRNSDirector/PDMR Shareholding
28th Nov 20143:42 pmRNSTotal Voting Rights
27th Nov 20143:15 pmRNSPublication of Supplementary Prospectus
25th Nov 20145:52 pmRNSAllotment and Issue of New Ordinary Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.